Anti-Diabetic Effects of Berberis kansuensis Extract on Type 2 Diabetic Rats Revealed by 1 H-NMR-Based Metabolomics and Biochemistry Analysis

Chem Biodivers. 2020 Oct;17(10):e2000413. doi: 10.1002/cbdv.202000413. Epub 2020 Sep 30.

Abstract

The dried stem bark of Berberis kansuensis C.K.Schneid. (Berberidaceae) was widely used to treat diabetes in traditional Tibetan medicine system. However, its anti-diabetic mechanisms have not been elucidated. In this study, 1 H-NMR-based metabolomics combined with biochemistry assay was applied to investigate the anti-diabetic activities as well as underlying mechanisms of B. kansuensis extract on type 2 diabetic rats. The results showed that after 30 days treatment with B. kansuensis extract, the levels of FBG, GSP, INS, TNF-α, IL-1β and IL-6 were significantly decreased in B. kansuensis group compared with the model group. Besides, a total of 28 metabolites were identified in rat serum by 1 H-NMR-based metabolomics method, 16 of which were significantly different in the normal group compared with the model group, and eight of them were significantly reversed after B. kansuensis intervention. Further analysis of metabolic pathways indicated that therapeutic effect of B. kansuensis might be predominantly related to their ability to improve glycolysis and gluconeogenesis, citric acid cycle, lipid metabolism, amino acid metabolism and choline metabolism. The results of both metabolomics and biochemical analysis indicated that B. kansuensis extract has a potential anti-diabetic effect on type 2 diabetic rats. Its therapeutic effect may be based on the ability of anti-inflammation, alleviating insulin resistance and restoring several disturbed metabolic pathways.

Keywords: Berberis kansuensis; NMR spectroscopy; biochemistry assay; biological activity; diabetes; metabolomics; pathway analysis.

MeSH terms

  • Animals
  • Berberis / chemistry*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / pharmacology*
  • Insulin / blood
  • Interleukin-1beta / blood
  • Interleukin-6 / blood
  • Male
  • Metabolomics*
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Proton Magnetic Resonance Spectroscopy
  • Rats
  • Rats, Sprague-Dawley
  • Serum Albumin / analysis
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Hypoglycemic Agents
  • IL1B protein, rat
  • Il6 protein, rat
  • Insulin
  • Interleukin-1beta
  • Interleukin-6
  • Plant Extracts
  • Serum Albumin
  • Tumor Necrosis Factor-alpha